Hepatitis a virus cell culture in vitro
    4.
    发明授权
    Hepatitis a virus cell culture in vitro 失效
    甲型肝炎病毒细胞培养体外

    公开(公告)号:US4164566A

    公开(公告)日:1979-08-14

    申请号:US934293

    申请日:1978-08-17

    摘要: Hepatitis A virus is passaged at least once in a susceptible sub-human primate; the infected liver from such passage is used to inoculate an in vitro cell culture, the inoculated cell culture is incubated until hepatitis A antigen is detected in the cell sheet or culture fluid, and at least two serial in vitro passages in cell culture are carried out. The hepatitis A virus so modified can be used to prepare live, attenuated hepatitis A vaccine or an inactivated hepatitis A vaccine.

    摘要翻译: {PG,1甲型肝炎病毒在易感亚人灵长类动物中传代至少一次; 将来自该传代的受感染的肝脏用于接种体外细胞培养物,孵育接种的细胞培养物直至在细胞片或培养液中检测到甲型肝炎抗原,并进行细胞培养中的至少两次连续体外传代 。 如此修饰的甲型肝炎病毒可用于制备活的,减毒的甲型肝炎疫苗或灭活的甲型肝炎疫苗。

    Hepatitis A antigen
    7.
    发明授权
    Hepatitis A antigen 失效
    甲型肝炎抗原

    公开(公告)号:US4029764A

    公开(公告)日:1977-06-14

    申请号:US530623

    申请日:1974-12-09

    CPC分类号: G01N33/5768

    摘要: Hepatitis A antigen obtained from the livers of non-human primates infected with hepatitis A (infectious hepatitis) virus has been found to be usable in fast, simple assays for hepatitis A antibody and thus usable in diagnosis of hepatitis A disease in humans, and for the preparation of hepatitis A vaccine.

    摘要翻译: 已经发现从感染甲型肝炎(感染性肝炎)病毒的非人灵长类动物的肝脏获得的甲型肝炎抗原可用于甲型肝炎抗体的快速,简单的测定中,因此可用于诊断人类中的甲型肝炎病毒 甲型肝炎疫苗的制备。

    Vaccine delivery system
    10.
    发明授权
    Vaccine delivery system 失效
    疫苗输送系统

    公开(公告)号:US4022206A

    公开(公告)日:1977-05-10

    申请号:US600983

    申请日:1975-08-01

    IPC分类号: A61M5/28 A61M5/00

    CPC分类号: A61M5/282 A61M5/288

    摘要: Vaccine delivery system having a lyophilized vaccine in human dosage concentration loaded into presterilized single dosage syringe having a squeezable body portion and a separate package containing enough water for injection to reconstitute the single dose of lyophilized vaccine.

    摘要翻译: 将具有人体剂量浓度的冻干疫苗的疫苗递送系统装载到具有可挤压主体部分的预杀灭的单剂量注射器中,以及包含足够的注射用水的单独包装以重构单剂量的冻干疫苗。